BioLineRx (BLRX) Net Equity Issued and Repurchased (2015 - 2018)
BioLineRx (BLRX) posted quarterly Net Equity Issued and Repurchased of $1.4 million for Q2 2018, down 94.57% year-over-year from $26.2 million in Q2 2017, and little changed quarter-over-quarter from $1.4 million in Q1 2018.
Powered by 
Analysis
BioLineRx (BLRX) Net Equity Issued and Repurchased (2015 - 2018) Analysis & Trends
BioLineRx's Net Equity Issued and Repurchased history runs 4 years deep, the most recent figure standing at $1.4 million for Q2 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | BioLineRx | 6.64 Bn | 6.64 Bn | 235,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | 1.42 Mn |
| Mar 31, 2018 | 1.42 Mn |
| Jun 30, 2017 | 26.23 Mn |
| Mar 31, 2017 | 2.09 Mn |
| Mar 31, 2016 | 1.60 Mn |
| Sep 30, 2015 | 199,000.00 |
| Jun 30, 2015 | 2.19 Mn |
| Mar 31, 2015 | 26.46 Mn |